` 4595 (Mizuho Medy Co Ltd) vs Nikkei 225 Comparison - Alpha Spread

4595
vs
Nikkei 225

Over the past 12 months, has underperformed Nikkei 225, delivering a return of 0% compared to the Nikkei 225's 7% drop.

Stocks Performance
4595 vs Nikkei 225

Loading
4595
Nikkei 225
Add Stock

Performance Gap
4595 vs Nikkei 225

Loading
4595
Nikkei 225
Difference

Performance By Year
4595 vs Nikkei 225

Loading
4595
Nikkei 225
Add Stock

Competitors Performance
Mizuho Medy Co Ltd vs Peers

Nikkei 225
4595
ABT
ISRG
BSX
SYK
Add Stock

Mizuho Medy Co Ltd
Glance View

Market Cap
34.4B JPY
Industry
Health Care

Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

Intrinsic Value
2 483.8 JPY
Undervaluation 8%
Intrinsic Value
Price
Back to Top